Peer Review Congress Chicago – Day 3

Good morning from Chicago! We will start Day 3 (last day) of the 10th International Congress on Peer Review and Scientific Publication. @peerreviewcongress.bsky.social / peerreviewcongress.org/peer-review-… #PRC10 <— This hashtag will give you all the posts! You can also click on this feed, created by @retropz.bsky.social: bsky.app/profile/did:…

[Day 1] and [Day 2].

Continue reading “Peer Review Congress Chicago – Day 3”

Discontinuous ridiculous stools – a preprint full of tortured phrases and stolen data

Patients with provocative entrail illness unclassified gave to crisis division a 3-day history of sickness, retching, migraine and irregular stomach torment alongside discontinuous ridiculous stools as of late.

If you cannot wrap your brain around this sentence, don’t worry. Neither can I.

A photo of a very ridiculous stool: a poop-emoji cake, with big white googly eyes and twisted candles on top. Taken at uBiome headquarters, March 2017.
Continue reading “Discontinuous ridiculous stools – a preprint full of tortured phrases and stolen data”

Preprint claiming that COVID-19 mRNA vaccines cause transcriptomic dysregulation is deeply flawed

Today, 25 July 2025, a preprint was posted claiming that significant gene expression changes were found in individuals with new-onset cancer and other diseases after receiving mRNA COVID-19 vaccines, compared to healthy individuals.

A preprint is a non-peer reviewed manuscript – a study or hypothesis that has not yet been evaluated by other scientists. These articles should always be read with caution. Preprints can be brilliant, misguided, or completely bonkers – but they have not been peer-reviewed.

So let’s take a closer look at this preprint.

Update, 12 September 2025: The preprint was withdrawn for “unresolved ethical issues concerning ethical oversight, legitimacy of institutional boards, validity of the study design, and potential biases in study interpretation that compromise the overall trust in the research findings.

Continue reading “Preprint claiming that COVID-19 mRNA vaccines cause transcriptomic dysregulation is deeply flawed”

Science Integrity Digest Summer 2025

It is hard to find the time to post here. I’m getting lots of requests to help scanning papers for image problems, and am also traveling a lot to give talks and be in panels. So my ‘monthly’ digests have now turned into quarterly digests, hahaha.

These past months, I have traveled to Berlin to receive the Einstein Foundation Award, to Oxford for the FAIRS Meeting, participated in a workshop in Stockholm organized by the Royal Swedish Academy of Sciences about the Reformation of Science Publishing, a conference in London at the Royal Society about the Future of Science Publishing, and a gathering with other science detectives and journalists in Krakow, Poland. In between, I gave several talks at research institutions and medical schools. I am getting pretty good at packing suitcases!

Here is a round-up of some noteworthy articles about research integrity.

Continue reading “Science Integrity Digest Summer 2025”

ScienceGuardians, where disgruntled authors complain about PubPeer

On Twitter/X, @SciGuardians, associated with the website ScienceGuardians.com, is promising to ‘uncover’ some big conspiracy of fraudulent @pubpeer.com users.

But in reality, the account appears to be run by one or more disgruntled scientists with dozens of problematic papers. And there is no big reveal.

Continue reading “ScienceGuardians, where disgruntled authors complain about PubPeer”

Science Integrity Digest – catching up

Apologies for not posting for a while. Fall 2024 was a busy time for me, with travel to give talks in Australia and Singapore and some events in the US. Instead of trying to catch up with everything that has happened since September, here are some highlights.

Einstein Foundation Award

I’m thrilled to have won the 2024 Einstein Foundation Award for Promoting Quality in Research. The Einstein Foundation Berlin selects three winners each year. The 2024 winners are:

  • Early Career Award: Helena Jambor and Christopher Schmied at PixelQuality – Best practices for publishing images. ‘PixelQuality has established guidelines and checklists for publishing clear and reproducible images. It now aims to disseminate and refine them to handle AI-assisted image generation and analysis.’ ‘Research images are the proof of scientific findings, not just visuals. PixelQuality has set new standards for their reproducibility and transparency.
  • Institutional Award: PubPeer – ‘PubPeer has become an essential part of the research communication landscape, with over 300,000 comments logged so far. It is estimated that since 2012, 19 percent of all retractions of papers worldwide in all academic domains had a prior discussion on the site. Beyond identifying flaws and fraud, PubPeer functions as an important tool to jointly improve scientific publications through „liquid feedback“.
  • Individual Award: Elisabeth Bik – ‘Elisabeth Bik’s work in uncovering manipulated images, fraudulent research data and publications has created enormous impact all over the world. Her work has led to heightened awareness of questionable research practices and generated widespread attention to responsible conduct of research in the scientific community.

The award ceremony will take place in March 2025 in Berlin, Germany.

The Einstein Foundation Award trophy is a piece of chalk, created by Professor Axel Kufus at the Berlin University of the Arts to honor ‘a basic tool that has been used to bring knowledge into the world for as long as we can remember’. Source: https://award.einsteinfoundation.de/about

The Bik Fund

Instead of accepting the Einstein Foundation award money for myself, I’ve decided to put it into ‘The Elisabeth Bik Science Integrity Fund’ – where I hope to help other science sleuths with small grants for e.g., traveling to conferences, buying equipment or software, or training. Our type of work often does not fit into the hypothesis-driven model of government or charity funds, so I hope to help by filling this funding gap.

The Bik Fund will be part of The Center For Scientific Integrity, Retraction Watch’s parent 501(c)3 non-profit organization.

It is my hope that we can make this fund grow, so we can help more integrity warriors in the future – donations to the Bik fund are tax-deductible and very welcome.

Press coverage:

Doctored

Charles Piller’s new book ‘Doctored – Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s’ came out earlier this month.

The book describes how Matthew Schrag, a neuroscientist at Vanderbilt University and a fellow image-sleuth, discovered possibly altered images in a highly-cited paper about amyloid plaques in Alzheimer’s patients and in other papers connected to the biotech company Cassava Sciences (see also below). It also gives a disturbing insight into the amount of fraud in neuroscience and the lack of action by journals, institutions, and government agencies.

Matthew Schrag and other ‘science sleuths’—Kevin Patrick, Mu Yang, and I—worked for two years checking thousands of papers in Alzheimer’s research and related fields for the book, uncovering a concerning number of potential problems in papers by Sylvain Lesné, Berislav Zlokovic, Eliezer Masliah, and others.

Press coverage of Piller’s book:

Podcasts with Charles Piller and/or Matthew Schrag (there are many more!)

Charles Piller (right) and I at a book signing event for ‘Doctored’ – February 2025 at the Commonwealth Club in San Francisco, CA

Cassava Sciences Phase 3 did not work

I have written in the past (here and here) about problematic images in papers by Dr. Hoau-Yan Wang and Cassava Sciences (NASDAQ: $SAVA), a biotech company testing a drug targeting Alzheimer’s disease. These concerns were first spotted by Matthew Schrag and published in a Citizen Petition, in an attempt to halt Cassava’s clinical trials. Despite the apparent problems, the FDA did not stop Cassava’s clinical trials of their Alzheimer’s drug, Simufilam. But Cassava’s stock dropped significantly, upsetting a lot of investors.

For three years, fans of the $SAVA stock harassed the Dr. Wang critics – including me – claiming that the drug would work fine; that all stockholders would be rich as long as they would HODL; and that all our concerns were FUD. They joined forces in a SAVAges Discord app, where they talked about how one day they would all buy Maseratis, Lamborghinis, and even a SAVA island — and how retarded and fraudulent the SAVA-critics were.

The authorities begged to differ, however. In March 2024, Science reported that FDA inspectors had found many problems in Dr. Wang’s lab, ranging from uncalibrated instruments, lack of control samples, and stored data files, to leaving out outliers based on subjective criteria. Another report by the City University of New York (CUNY) to the Office of Research Integrity (ORI), leaked to Science, described ‘egregious misconduct’ in Dr. Wang’s lab. In June last year the Department of Justice announced that Professor Wang had been charged with operating a ‘Multimillion-Dollar Grant Fraud Scheme’.

Meanwhile, lawsuits were filed back-and-forth. Cassava Sciences was suing the people who filed the FDA citizen petition and who set up the website CassavaFraud.com, while stockholders were suing Cassava in a class-action lawsuit for misrepresenting the quality of the experiments performed by Dr. Wang. The Securities and Exchange Commission (SEC) charged Cassava with misrepresenting clinical trials result, and later settled for $40M. And CUNY, instead of officially announcing their misconduct findings, was investigating who leaked their misconduct investigation report to Science.

Finally, last December the biotech company announced that the Phase 3 trial did not meet the anticipated endpoints. In other words, Simufilam did not halt or improve Alzheimer’s disease. The Cassava Sciences stock immediately dropped to $2-3 dollars, and the SAVAges Discord became a valley of despair. No more SAVA island.

$SAVA stock price, last 5 years. Source: https://www.nasdaq.com/market-activity/stocks/sava

Didier Raoult enters the Retraction Watch Leaderboard

As I’ve written previously, many papers from Professor Didier Raoult, the former director of the IHU Méditerranée Infection in Marseille, France, are problematic.

Some appear to contain manipulated images, while others describe research conducted without proper ethical permits. A number of Raoult’s studies were performed on vulnerable populations, such as homeless people, or on study participants in the Global South, which I [gasp!] dared to label neocolonial science.

As described in this paper by Fabrice Frank et al, the IHU-MI produced a set of 248 studies all with the same IRB approval number, 09–022. Despite sharing the same permit, the publications varied in terms of sample type, demographics, and countries. Other ‘multi-use’ IRB numbers were found too. Typically, an IRB approves one particular study, and researchers are not allowed to reuse this permit for other, unrelated, studies. Dr. Raoult appears to have cared little for such rules, however.

After raising our concerns on PubPeer and social media, and also writing to journal editors, several journals have started to issue Expressions of Concern and retractions.

Fabrice Frank has generated a list of all IHU-MI papers with concerns – there are over 800!

In fact, Raoult has now earned so many retractions (32 as of today) that he has entered the Retraction Watch Leaderboard. The most significant of them is the retraction of the paper that claimed that Hydroxychloroquine could treat COVID-19. I criticized this paper in my blog post in April 2020, days after its publication. It took more than four years to get it retracted.

With over 600 of his papers on PubPeer and 225 EoCs, it seems safe to assume that for Raoult’s position on the Retraction Watch Leaderboard list, the only way is up.

Artist: Sara Gironi Carnevale. Source: https://www.science.org/content/article/failure-every-level-how-science-sleuths-exposed-massive-ethics-violations-famed-french

Science Integrity Digest, September 2024

An overview of general news and articles about science integrity and some cases that I have worked on.

Science sleuths

Neuroscientist and top NIH official under scrutiny

Q-Collar under scrutiny

Nobel prize winner under scrutiny

Paper Mills

New ORI regulations

The US Office of Research Integrity updated its regulations on handling research misconduct allegations. Key updates include clarifying the inquiry process and adjusting how institutions should handle the allegations and record the process.

1 in 7 scientific articles might be fake

James Heathers published a preprint arguing that the old, often-cited number that 2% of papers are fake is outdated and a vast underestimate. In a new preprint, he argues it might be 1 in 7 papers, based on 12 studies that together analyze 75,000 scientific articles.

Francesca Gino lawsuit

Around the world

New Publication and Editorials

Retraction Watch’s Weekend Reads:

Science Integrity Digest, August 2024

Your monthly digest of science integrity news.

General Science Integrity News

Sleuthing

Legal threats for science critics

Federal and institutional investigations

Publishers taking action

Games

Artificial intelligence and science

New Publication and Editorials

Retraction Watch’s Weekend Reads:

Science Integrity Digest, June 2024

A round-up from last month, with news articles about science integrity, retractions of several highly cited papers in the fields of Alzheimer’s disease and stem cell research, generative AI and misconduct, and another retraction for Didier Raoult.

General Science Integrity News

Highly cited Alzheimer’s paper retracted by Nature

  • Daily briefing: Landmark Alzheimer’s paper will be retracted. Senior author plans to retract her team’s highly cited study on the cause of Alzheimer’s disease after acknowledging that the paper contains manipulated images. Plus, why cicadas shriek so loudly and how CO2 helps viruses stay alive in the air. – Flora Graham – Nature Briefing
  • Alzheimer’s study pulled over data tampering. American university researchers insist their main findings still stand in dementia paper that had been cited 2,500 times. It is the most-cited paper ever to be retracted, according to Retraction Watch, a group that flags dubious research and regularly finds signs of evidence tampering. – Rhys Blakely – The Times UK
  • After Amyloid. Authors of a landmark Alzheimer’s disease research paper published in Nature in 2006 have agreed to retract the study in response to allegations of image manipulation. University of Minnesota (UMN) Twin Cities neuroscientist Karen Ashe, the paper’s senior author, acknowledged in a post on the journal discussion site PubPeer that the paper contains doctored images. – Mike Barr – POZ
  • Do we have Alzheimer’s disease all wrong?
    Retracted studies and new treatments reveal the confusing state of Alzheimer’s research. The authors of the retracted paper in question, which was published in Nature in 2006 and claimed to identify a specific target for future drug development, agreed to withdraw their research in full, two years after a stunning investigation by Science found that key images had been doctored.
    Dylan Scott – Vox
  • Alzheimer : les dessous de la fraude scientifique derrière l’une des études les plus influentes. Il y a deux ans, un chercheur jusqu’ici inconnu formulait des accusations de fraude contre l’un des articles scientifiques les plus importants au monde. Il vient d’obtenir gain de cause. Antoine Beau – L’Express [In French]
  • Retraction, 26 June 2024: https://www.nature.com/articles/s41586-024-07691-8

Even higher cited stem cell paper retracted by Nature

About 17 years after New Scientist investigators Eugenie Reich and Peter Aldhous revealed problems in a Nature 2002 paper about making adult stem cells pluripotent (see 2007 articles in New Scientist and New York Times and this recent X thread here), and more than four years after I found additional problems in that paper (PubPeer), Nature decided to retract it. Meanwhile, it has been cited nearly 4,500 times.

Other notable misconduct findings

Another retraction for Didier Raoult

The International Journal of Obesity retracted an article on which Didier Raoult was the corresponding and last author, “because the authors could not confirm approval from an appropriate ethics committee to recruit healthy donors to provide samples for use in this research.”According to the Retraction Watch Database, this is his 13th retraction. The paper had been flagged on PubPeer because it was one of five papers with the same local approval number, while it appeared to not have CPP approval (regional IRB-like approval needed in France for human subjects research). Read more about the problems in Raoult’s papers here, here, and here.

Artificial intelligence and science misconduct

A (now-retracted) paper featuring an AI-generated rat with a giant penis has caused a lot of laughs on social media. But AI is capable of making much more believable images. Is the scientific publishing world ready for a tsunami of fake photos and dataset? And how can we use AI tools to actually detect fraud? Also see below in the new publication list.

Science Integrity around the world

Interviews with science sleuths

New publications and editorials

Retraction Watch’s Weekend Reads:

Science Integrity Digest, May 2024

A digest of last month’s news articles, retractions, and scientific publications about science integrity and misconduct. Some articles might be behind a paywall. Let me know in the comments if I missed something!

Continue reading “Science Integrity Digest, May 2024”